Found 64 matching trials
A Study of Rebif® in Subjects With Relapsing Multiple Sclerosis PHASE4 This is an open-label, multi-center, 12-week, randomized, controlled, paral...
Show More Location
Please contact the Merck KGaA Communication Center
Learn More & Join Trial
Combination Therapy Using Cellcept and Rebif in RRMS EARLY_PHASE1 The purpose of this trial is to examine the benefits of early combination o...
Show More Location
The Ohio State University Multiple Sclerosis Center
Learn More & Join Trial
Open Label Study of Tolerability, Pharmacokinetics and Pharmacodynamics of BCD-054 (Pegylated Interferon Beta-1a), IM and SC, Compared to Rebif® and Avonex® in Healthy Volunteers PHASE1 This is an international multicenter study of tolerability, pharmacokinetic...
Show More Learn More & Join Trial
the Investigation Into Beneficial Effects of High-dose Interferon Beta 1-a, Compared to Low-dose Interferon Beta 1-a in Moderate to Severe Covid-19 PHASE2 The present study is a randomized clinical trial, with the approval of the ...
Show More Location
Multiple Locations
Learn More & Join Trial
Study to Determine if Avonex and Rebif Work Comparably Well in Subjects With Relapsing Multiple Sclerosis N/A The purpose of this study is to find out if weekly Avonex works as well as ...
Show More Learn More & Join Trial
Avonex®: Safety, Blood Levels and Effects PHASE1 The primary objective was to determine the tolerability of a new inhaled fo...
Show More Location
Hammersmith Medicines Research
Learn More & Join Trial
MATRIX: Measuring Neutralizing Antibodies in the Patients Treated With Interferon Beta 1a IM, in Mexico and Colombia PHASE4 This is a cross sectional Phase 4, multicenter, study of AVONEX® and JUMTAB...
Show More Learn More & Join Trial
Patients With Relapse Remitting Multiple Sclerosis (RRMS): Candidates for MS Therapy Change PHASE4 The purpose of this study is to evaluate the change in patient-reported tre...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Study of Evobrutinib in Participants With Relapsing Multiple Sclerosis (RMS) PHASE3 The study was to evaluate the efficacy and safety of evobrutinib administer...
Show More Location
Please Contact U.S. Medical Information
Learn More & Join Trial
Study To Evaluate The Immunogenicity And Safety Of r-hIFN Beta-1a (Rebif®) Using Clone 484-39 In Multiple Sclerosis PHASE4 The objectives of the study are:
\- comparison of the incidence and time c...
Show More Location
Multiple Locations
Learn More & Join Trial